Surgery Doctors in Delta, CO Accepting Medicare

6 Surgery doctors found. Showing 1 - 6

Dr. William Cole, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1501 E 3rd St # Na, Delta, CO 81416 Phone: 970-874-7681

Patrick A Brighton, MD Surgery Medicare: Medicare Enrolled Practice Location: 95 Stafford Ln, Delta, CO 81416 Phone: 970-874-8026

Laura Mccrackin, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 95 Stafford Ln, Delta, CO 81416 Phone: 970-874-8026

John Christian Sinclair, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1902 1600 Rd, Delta, CO 81416 Phone: 970-250-0781

Dr. Kyle Christian Nickel, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 95 Stafford Ln # Na, Delta, CO 81416 Phone: 970-874-8026    Fax: 970-874-5043

Nick D Hattel, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1501 E 3rd St, Delta, CO 81416 Phone: 970-874-7681

News Archive

New anti-clotting therapy no better than established anticoagulants

A novel therapy that would allow doctors to turn the body's blood-clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing angioplasty but was associated with higher rates of moderate to severe bleeding, according to an analysis of data from a terminated Phase III trial presented at the American College of Cardiology's 64th Annual Scientific Session.

Sermo announces a new report on evolving trends in CML

Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.

Researchers develop new device that can change current landscape of chronic wound management

Complex wounds affect more patients in the United States than heart attack and stroke combined, and five to seven million Americans with complex wounds account for over $20 billion in healthcare expenditures. About 150,000 amputations a year result from complex wounds, while about 80,000 are attributed to diabetes and peripheral arterial disease.

The Advisory Board Company announces fiscal 2010 second-quarter results

The Advisory Board Company today announced financial results for the second quarter of its fiscal year ending March 31, 2010. Revenue for the quarter increased 1.2% to $58.3 million, from $57.6 million in the second quarter of fiscal 2009. Contract value grew 3.0% to $237.6 million as of September 30, 2009, up from $230.6 million as of September 30, 2008.

Read more Medical News

› Verified 4 days ago